C4 Therapeutics (CCCC) IPO Opens 40% Higher

Today's IPO for C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC) opened for trading at $26.60 after pricing of its upsized initial public offering of 9.6 million shares of common stock at a public offering price of $19 per share.

Additionally, C4T has granted the underwriters a 30-day option to purchase up to an additional 1.44 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank are acting as joint book-running managers for the offering.

You May Also Be Interested In

• YPF Energía Eléctrica S.A. files for proposed NYSE IPO
• Research Alliance Corporation IV prices $75M IPO on Nasdaq
• Columbus Circle Capital Corp. III closes $230M IPO on Nasdaq